Hardik Bhatt

1.7k total citations
64 papers, 1.3k citations indexed

About

Hardik Bhatt is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Hardik Bhatt has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Organic Chemistry and 13 papers in Computational Theory and Mathematics. Recurrent topics in Hardik Bhatt's work include Synthesis and biological activity (22 papers), Computational Drug Discovery Methods (13 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Hardik Bhatt is often cited by papers focused on Synthesis and biological activity (22 papers), Computational Drug Discovery Methods (13 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Hardik Bhatt collaborates with scholars based in India, United States and Belgium. Hardik Bhatt's co-authors include Vivek K. Vyas, Colin L. Stewart, John F. Klement, C A Rosen, Nancy R. Rice, Gordon Powers, Bruce D. Car, Bhumika Patel, Susan J. Abbondanzo and Christophe Pannecouque and has published in prestigious journals such as Molecular and Cellular Biology, RSC Advances and Behavioural Brain Research.

In The Last Decade

Hardik Bhatt

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hardik Bhatt India 20 576 361 245 232 222 64 1.3k
Ganesha Rai United States 26 1.3k 2.3× 311 0.9× 142 0.6× 151 0.7× 175 0.8× 90 2.2k
Tomohiro Kawamoto Japan 24 1.1k 1.9× 473 1.3× 179 0.7× 243 1.0× 301 1.4× 61 1.9k
Hariprasad Vankayalapati United States 21 1.5k 2.7× 280 0.8× 180 0.7× 227 1.0× 257 1.2× 61 2.2k
Adrienne L. Edkins South Africa 24 902 1.6× 249 0.7× 156 0.6× 207 0.9× 332 1.5× 91 1.7k
Shingo Dan Japan 26 1.4k 2.4× 278 0.8× 294 1.2× 149 0.6× 493 2.2× 95 2.3k
Lise R. Hoth United States 16 1.5k 2.5× 287 0.8× 113 0.5× 230 1.0× 171 0.8× 24 2.2k
Landon R. Whitby United States 19 914 1.6× 452 1.3× 77 0.3× 201 0.9× 191 0.9× 24 1.4k
M. Kyle Hadden United States 23 1.3k 2.2× 182 0.5× 139 0.6× 75 0.3× 264 1.2× 77 1.8k
Yongliang Yang China 23 885 1.5× 122 0.3× 191 0.8× 170 0.7× 254 1.1× 64 1.4k
David Fox United States 24 1.1k 2.0× 564 1.6× 120 0.5× 113 0.5× 237 1.1× 39 2.0k

Countries citing papers authored by Hardik Bhatt

Since Specialization
Citations

This map shows the geographic impact of Hardik Bhatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hardik Bhatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hardik Bhatt more than expected).

Fields of papers citing papers by Hardik Bhatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hardik Bhatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hardik Bhatt. The network helps show where Hardik Bhatt may publish in the future.

Co-authorship network of co-authors of Hardik Bhatt

This figure shows the co-authorship network connecting the top 25 collaborators of Hardik Bhatt. A scholar is included among the top collaborators of Hardik Bhatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hardik Bhatt. Hardik Bhatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Patel, Bhumika, et al.. (2025). Structure-guided computational design of novel polycyclic aromatic compounds as telomerase inhibitors for the treatment of cancer. Network Modeling Analysis in Health Informatics and Bioinformatics. 14(1).
3.
Bhatt, Hardik, et al.. (2025). The Future of Medicine: AI and ML Driven Drug Discovery Advancements. Current Topics in Medicinal Chemistry. 25(16). 1957–1978. 1 indexed citations
4.
Bhatt, Hardik, et al.. (2024). Synthesis, biological screening, and binding mode analysis of some N-substituted tetrahydroquinoline analogs as apoptosis inducers and anticancer agents. Journal of Molecular Structure. 1318. 139330–139330. 6 indexed citations
6.
Patel, Bhumika, et al.. (2024). Evolution of Telomerase Inhibitors: A Review on Key Patents from 2015 to 2023. ChemistrySelect. 9(47). 4 indexed citations
7.
Patel, Saumya, et al.. (2023). New molecular insights for 4 H -1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. 41(22). 13496–13508. 3 indexed citations
8.
Patel, Bhumika, et al.. (2022). Tetrahydroquinoline: An Efficient Scaffold As mTOR Inhibitor for the Treatment of Lung Cancer. Future Medicinal Chemistry. 14(23). 1789–1809. 13 indexed citations
9.
Sagar, Sneha R., et al.. (2022). A search for potential anti-HIV phytoconstituents from the natural product repository. Advances in Traditional Medicine. 23(4). 953–984. 2 indexed citations
10.
Rawal, Rakesh, et al.. (2020). Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer. Bioorganic Chemistry. 106. 104501–104501. 21 indexed citations
12.
Patel, Bhumika, et al.. (2016). Design, synthesis and anti-HIV activity of novel quinoxaline derivatives. European Journal of Medicinal Chemistry. 117. 230–240. 51 indexed citations
14.
Bhatt, Hardik, et al.. (2013). QUANTIFICATION OF POTENTIAL GENOTOXIC IMPURITY IN IMATINIB MESYLATE BY LC-MS/MS. 3(2). 182–191. 3 indexed citations
15.
Vyas, Vivek K., et al.. (2013). Therapeutic potential of snake venom in cancer therapy: current perspectives. Asian Pacific Journal of Tropical Biomedicine. 3(2). 156–162. 122 indexed citations
16.
Vyas, Vivek K., Hardik Bhatt, Pankaj Kumar Patel, et al.. (2013). CoMFA and CoMSIA studies onC-aryl glucoside SGLT2 inhibitors as potential anti-diabetic agents. SAR and QSAR in environmental research. 24(7). 519–551. 26 indexed citations
17.
Bhatt, Hardik & Paresh K. Patel. (2012). Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(11). 3758–3765. 19 indexed citations
18.
Agrawal, Y. K., et al.. (2007). Emerging trends in tuberculosis therapy : A review. Journal of Scientific & Industrial Research. 66(3). 191–208. 4 indexed citations
19.
Manna, Kuntal, et al.. (2007). Synthesis and biological evaluations of new benzofuran 1,3,5-trisubstituted pyrazoline derivatives of paracetamol as potential antitubercular, antimicrobial agents. 16(3). 263–266. 7 indexed citations
20.
Agrawal, Y. K., Hitesh Vaidya, Hardik Bhatt, Kuntal Manna, & Pathik S. Brahmkshatriya. (2007). Recent advances in the treatment of thromboembolic diseases: Venous thromboembolism. Medicinal Research Reviews. 27(6). 891–914. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026